Eledon Pharmaceuticals, Inc. (ELDN)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-56.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | $0 |
| Operating Income | — | — | -$43.00M | -$88.43M | -$36.87M | -$18.46M | -$16.05M | -$14.06M | -$13.12M | -$5.13M |
| Net Income | -$45.62M | -$36.18M | -$116.54M | -$87.97M | -$34.51M | -$22.81M | -$16.01M | -$14.06M | -$13.12M | -$5.66M |
| EPS (Diluted) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | — | — | — | — | — |
| Total Assets | $169.01M | $177.41M | $89.07M | $92.79M | $170.55M | $197.19M | $10.93M | $17.03M | $20.89M | $1.20M |
| Total Liabilities | $32.23M | $59.27M | $81.86M | $8.61M | $6.55M | $6.59M | $1.47M | $2.53M | $1.44M | $3.90M |
| Shareholders' Equity | $81.08M | $62.45M | -$48.49M | $23.79M | $164.00M | $190.60M | $9.46M | $14.49M | $19.45M | -$2.70M |
| Cash & Equivalents | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M | $114.19M | $8.79M | $12.97M | $17.23M | $1.10M |
| Operating Cash Flow | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M | -$15.21M | -$13.86M | -$11.89M | -$14.94M | — |
| Capital Expenditures | — | — | — | — | — | — | — | — | — | $9.0K |
| Shares Outstanding | 75.43M | 59.79M | 24.21M | 13.78M | 14.31M | 15.16M | 720.4K | 9.42M | 7.11M | 394.3K |